← Back to Clinical Trials
Recruiting NCT05767658

NCT05767658 Support Via Online Social Networks to Promote Safe Infant Care Practices

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05767658
Status Recruiting
Phase
Sponsor University of Virginia
Condition Breastfeeding
Study Type INTERVENTIONAL
Enrollment 3,000 participants
Start Date 2024-03-01
Primary Completion 2026-07-01

Eligibility & Interventions

Sex Female only
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Safe SleepBreastfeedingEarly Brain Development and Parent-Child Relationships

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 3,000 participants in total. It began in 2024-03-01 with a primary completion date of 2026-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to improve adherence to American Academy of Pediatrics safe sleep (SS) recommendations and improve rates of initiation and duration of partial and exclusive breastfeeding (BF); and reduce Black/White disparities in these practices through the use of private Facebook groups providing a) evidence-based education through videos and other multi-media supporting best practices and b) an online community and social network of other pregnant WIC clients and new parents.

Eligibility Criteria

Inclusion Criteria: * Currently enrolled in WIC, or it not, then have either Medicaid or no health insurance * Must be English speaking * Must be pregnant and less than 30 weeks gestation * Must live in the United States * Must have regular access to Facebook and short message service (SMS) texting (mobile phone) Exclusion Criteria: * Not planning to live in same home as infant after birth. * Prenatal diagnosis expected to impact on infant care practices in a manner not compatible with study goals, including contraindications to feeding any breastmilk or supine infant sleep positioning. * Known or reported mental health or other issues that would preclude custody of the infant or being able to participate in the informed consent process. * Meets the definition of a minor according to applicable state law. * Participants who consent to participation in the study, must complete the Agile Onboarding process before they reach 30+0 weeks gestation. * Currently or previously received a TodaysBaby educational program (randomized to a TodaysBaby program through either the SMARTER, or SUPERSONIC study), either in their current or a previous pregnancy.

Contact & Investigator

Central Contact

Katherine Boguszewski, MA

✉ Keb5un@uvahealth.org

📞 434-243-9663

Principal Investigator

Rachel Y Moon, MD

PRINCIPAL INVESTIGATOR

University of Virginia School of Medicine

Frequently Asked Questions

Who can join the NCT05767658 clinical trial?

This trial is open to female participants only, studying Breastfeeding. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05767658 currently recruiting?

Yes, NCT05767658 is actively recruiting participants. Contact the research team at Keb5un@uvahealth.org for enrollment information.

Where is the NCT05767658 trial being conducted?

This trial is being conducted at Boston, United States.

Who is sponsoring the NCT05767658 clinical trial?

NCT05767658 is sponsored by University of Virginia. The principal investigator is Rachel Y Moon, MD at University of Virginia School of Medicine. The trial plans to enroll 3,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology